| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |